Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|February 24, 2023
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive diseaseAlyne Condurú Dos Santos Cunha, Adrian Georg Simon, Thomas Zander, et al.Journal of Immunology Research|October 8, 2020
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal AdenocarcinomaHeike Loeser, Max Kraemer, Florian Gebauer, et al.Therapeutic Advances in Medical Oncology|June 18, 2020
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategiesValeska Moentenich, Erdem Comut, Florian Gebauer, et al.Scientific Reports|December 1, 2022
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinomaAlexander I Damanakis, Isabell Wahler, Hans Fuchs, et al.International Journal of Cancer|August 23, 2011
ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patientsMichael Tachezy, Katharina Effenberger, Hilke Zander, et al.Oncology Letters|May 12, 2020
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategiesValeska Moentenich, Florian Gebauer, Erdem Comut, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancerTobias Lange, Mareike Kupfernagel, Daniel Wicklein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic CancerKatharina E Effenberger, Cornelia Schroeder, Annkathrin Hanssen, et al.World Journal of Surgery|September 23, 2011
Multivisceral resections in pancreatic cancer: identification of risk factorsChristoph M Burdelski, Matthias Reeh, Dean Bogoevski, et al.Journal of Surgical Oncology|April 27, 2011
Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinomaFlorian Gebauer, Michael Tachezy, Katharina Effenberger, et al.Pageof 11